HIF1α-AS2 is upregulated in breast cancer tissue compared to adjacent normal tissues and is associated with poor clinical outcome in patients entailing advanced tumor grade, lymph node metastasis, and distant metastasis, along with shorter overall survival (101). Here, HIF1A is linked to breast cancer.